MEDICON Anti-inflammatory, Anti-cancer, and Anti-angiogenic Compounds Patent
Summary
The USPTO granted patent US12599599B2 to MEDICON PHARMACEUTICALS, INC. covering compounds of general Formula A-D-Y with anti-inflammatory, anti-cancer, and anti-angiogenic activity for treating inflammation, cancer, neurodegenerative diseases, and cardiovascular diseases. The patent includes pharmaceutical compositions, methods of making, and methods of use with 4 claims.
What changed
The USPTO granted patent US12599599B2 to MEDICON PHARMACEUTICALS, INC. covering compounds of Formula A-D-Y with anti-inflammatory, anti-cancer, and anti-angiogenic activity for treating diseases related to inflammation, cancer, neurodegenerative diseases, and cardiovascular diseases. The patent includes 4 claims on pharmaceutical compositions, methods of making, and methods of use.
For pharmaceutical companies and manufacturers developing therapeutics in these disease areas, this patent establishes exclusionary rights that may affect freedom-to-operate assessments and competitive landscape analysis for anti-inflammatory, anti-cancer, and cardiovascular drug development programs.
What to do next
- Monitor for updates
Archived snapshot
Apr 14, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Anti-inflammatory, anti-cancer, and anti-angiogenic compounds, pharmaceutical compositions, and methods of making and using thereof
Grant US12599599B2 Kind: B2 Apr 14, 2026
Assignee
MEDICON PHARMACEUTICALS, INC.
Inventors
Basil Rigas
Abstract
Compounds of the general Formula A-D-Y are disclosed with activity towards treating diseases related to inflammation, cancer, neurodegenerative diseases, and cardiovascular diseases. Pharmaceutical compositions, methods of making, and methods of use thereof are also described.
CPC Classifications
A61P 27/02 A61P 35/00 A61P 27/04 A61P 29/00 C07C 233/78 C07C 323/62 C07C 317/44 C07D 241/04 C07D 295/185 C07F 9/222 C07F 9/2458 C07F 9/650952
Filing Date
2023-07-20
Application No.
18355811
Claims
4
Related changes
Get daily alerts for USPTO Patent Grants - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.